Boxer Capital, LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 144 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2021. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
Boxer Capital, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q2 2021$10,575,000
-24.6%
500,0000.0%0.37%
-21.6%
Q1 2021$14,025,000
+7.9%
500,0000.0%0.48%
+13.9%
Q4 2020$13,000,000
-64.1%
500,000
-48.7%
0.42%
-66.6%
Q3 2020$36,241,000
-27.6%
975,0000.0%1.25%
-43.1%
Q2 2020$50,027,000
+62.7%
975,0000.0%2.20%
+5.0%
Q1 2020$30,742,000
-47.1%
975,0000.0%2.10%
-36.3%
Q4 2019$58,139,000
+62.7%
975,0000.0%3.29%
+26.9%
Q3 2019$35,744,000
-21.2%
975,0000.0%2.59%
-33.5%
Q2 2019$45,357,000
+15.9%
975,0000.0%3.90%
-13.9%
Q1 2019$39,146,000
-29.1%
975,000
-18.8%
4.53%
-33.6%
Q4 2018$55,200,000
-9.5%
1,200,000
-12.7%
6.82%
+0.7%
Q3 2018$61,009,000
+13.2%
1,375,0000.0%6.77%
+10.9%
Q2 2018$53,886,000
-17.2%
1,375,000
+52.8%
6.10%
-12.2%
Q1 2018$65,097,000
+23.6%
900,000
+12.5%
6.95%
-27.8%
Q4 2017$52,672,000
+110.2%
800,000
+60.0%
9.63%
+68.7%
Q3 2017$25,060,000
-45.9%
500,000
-50.0%
5.70%
-48.2%
Q2 2017$46,280,000
+2.8%
1,000,000
-21.6%
11.01%
+11.9%
Q1 2017$45,020,0001,275,0009.84%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q2 2021
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders